Sort by
Refine Your Search
-
with mouse models of neurodegenerative diseases, demyelinating conditions, and brain tumors • Expertise in flow cytometry, including high-dimensional (spectral) flow cytometry for immune phenotyping
-
induced pluripotent stem cells derived cardiac organoids for disease modeling and gene editing. This research aims to deepen our understanding of dystrophic cardiomyopathy and develop novel therapeutic
-
(Including histone modification and DNA methylation) and 3D genome organization studies on the interplay between EBV infection and host interactions. Using in vitro B cell transformation model and 3D organoid
-
. In particular we use the promiscuous pregnane X receptor (PXR) and constitutive androstane receptor (CAR) as models. PXR and CAR transcriptionally regulate cytochrome P450 3A4 (CYP3A4) and CYP3A5-drug
-
working with preclinical models • Experience in one or more of following methods: in vivo behavior, small animal surgery, RNA, DNA, protein extraction and measurement, cell culture, histology
-
expertise in T cell and dendritic cell biology • Extensive hands-on experience with mouse models of infection, inflammation, and immune memory • Proficient in flow cytometry, including high-dimensional and
-
mechanisms • Extensive hands-on experience with murine models of liver injury, fibrosis, and regeneration, including tissue dissection and downstream analysis • Proficient in flow cytometry, including high
-
statistical methods to agronomic research, including mixed models, geospatial statistics, multivariate analysis, and machine learning - Must possess and maintain an active and valid driver’s license Preferred
-
stratification dynamics. This person in this position will also assist with the development of a model focused on the production of methane by methanogens and degradation by methanotrophs. The postdoctoral
-
-tuning DNA sequence/genomic/omic large language models (gLLMs) with their applications to genetics, e.g. in identifying causal genes for Alzheimer’s disease (AD). You will have access to state-of-the-art